 |
 |
 |
 |
 |
|
|
| Article 1 to 6 out of 6 concerning Elsevier B.V.
|
-
Regular Analgesic Use Increases Hearing Loss in Men
(02 Mar 2010)
In a study published in The American Journal of Medicine, researchers determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of hearing loss in men, particularly in younger men, ...
-
New Study Indicates Smallpox Vaccination Effective for Decades
(02 Dec 2008)
Implications for Vaccine Distribution in Event of Bioterrorist Attack
Although naturally occurring smallpox was eradicated in 1977, there is concern that bioterrorists might obtain smallpox from a laboratory and release it into the population. Under such circumstances, the supply of smallpox vaccine may be ...
-
New 'trick' allows HIV to overcome a barrier to infection
(08 Sep 2008)
Researchers have discovered a new 'trick' that allows HIV to overtake resting T cells that are normally highly resistant to HIV infection, according to a report in Cell, a Cell Press publication. The binding of the virus to the surface of those ...
-
Tadalafil shows promise for relief of lower urinary tract symptoms associated with BPH
(20 Aug 2008)
Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of tadalafil (Cialis®) to relieve associated lower urinary tract symptoms (LUTS), according to a new study published in The Journal of Urology. Researchers from ...
-
Elsevier Acquires Windhover Information Inc., a Healthcare Business Intelligence Company
(12 Mar 2008)
Elsevier announced that it has acquired Windhover Information Inc., a healthcare business intelligence company that provides analysis and commentary on healthcare business strategy, industry deal making, marketplace trends and medical ...
-
Elsevier Signs Agreement With Seven Virginia Universities
(14 Apr 2004)
Deal Brings Scientific and Medical Information to the James Madison University Cooperative (JMUC)
Amsterdam, Netherlands. Elsevier and the James Madison University Cooperative (JMUC) announced today that they have signed a five-year agreement for the provision of vital scientific and medical information.The agreement provides the over ...
 |
|
|
|
|